메뉴 건너뛰기




Volumn 49, Issue 3, 2005, Pages 421-422

Long term results of CHART and weekly Paclitaxel in locally advanced non-small cell lung cancer [3]

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

EID: 23744479383     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.03.028     Document Type: Letter
Times cited : (3)

References (7)
  • 1
    • 0032828642 scopus 로고    scopus 로고
    • Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer
    • E.N. Oral, S. Bavbek, A. Kizir, N. Tenekeci, A. Yoney, and E. Kaytan Preliminary analysis of a phase II study of Paclitaxel and CHART in locally advanced non-small cell lung cancer Lung Cancer 25 1999 191 198
    • (1999) Lung Cancer , vol.25 , pp. 191-198
    • Oral, E.N.1    Bavbek, S.2    Kizir, A.3    Tenekeci, N.4    Yoney, A.5    Kaytan, E.6
  • 2
    • 0033179899 scopus 로고    scopus 로고
    • Continuous, hyperfactionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. CHART Steering Comittee
    • M. Saunders, S. Dische, A. Barrett, A. Harvey, G. Griffiths, and M. Palmar Continuous, hyperfactionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering Comittee Radiother Oncol 52 1999 137 148
    • (1999) Radiother Oncol , vol.52 , pp. 137-148
    • Saunders, M.1    Dische, S.2    Barrett, A.3    Harvey, A.4    Griffiths, G.5    Palmar, M.6
  • 3
    • 0032858243 scopus 로고    scopus 로고
    • Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer
    • K. Furuse, K. Fukuoka, M. Kawahara, H. Nishikawa, Y. Takada, and S. Kudoh Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer J Clin Oncol 17 1999 2692 2699
    • (1999) J Clin Oncol , vol.17 , pp. 2692-2699
    • Furuse, K.1    Fukuoka, K.2    Kawahara, M.3    Nishikawa, H.4    Takada, Y.5    Kudoh, S.6
  • 4
    • 0346236869 scopus 로고    scopus 로고
    • Long term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410
    • W.J. Curran, C.B. Scott, C.J. Langer, R. Komaki, J.S. Lee, and S. Hauser Long term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410 Proc ASCO 22 2003 621a
    • (2003) Proc ASCO , vol.22
    • Curran, W.J.1    Scott, C.B.2    Langer, C.J.3    Komaki, R.4    Lee, J.S.5    Hauser, S.6
  • 5
    • 0036786730 scopus 로고    scopus 로고
    • Fatal pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced non-small cell lung cancer
    • P. Kirkbride, M. Hatton, P. Lorigan, P. Joyce, and P. Fisher Fatal pulmonary fibrosis associated with induction chemotherapy with carboplatin and vinorelbine followed by CHART radiotherapy for locally advanced non-small cell lung cancer Clin Oncol 14 2002 361 366
    • (2002) Clin Oncol , vol.14 , pp. 361-366
    • Kirkbride, P.1    Hatton, M.2    Lorigan, P.3    Joyce, P.4    Fisher, P.5
  • 6
    • 0037625004 scopus 로고    scopus 로고
    • Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART)
    • P. Jenkins, K. D'Amico, K. Benstead, and S. Elyan Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART) Int J Radiat Oncol Biol Phys 56 2003 360 366
    • (2003) Int J Radiat Oncol Biol Phys , vol.56 , pp. 360-366
    • Jenkins, P.1    D'Amico, K.2    Benstead, K.3    Elyan, S.4
  • 7
    • 0037216434 scopus 로고    scopus 로고
    • Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer
    • K. Tsujino, S. Hirota, M. Endo, K. Obayashi, Y. Kotani, and M. Satouchi Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer Int J Radiat Oncol Biol Phys 55 2003 110 115
    • (2003) Int J Radiat Oncol Biol Phys , vol.55 , pp. 110-115
    • Tsujino, K.1    Hirota, S.2    Endo, M.3    Obayashi, K.4    Kotani, Y.5    Satouchi, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.